SCHEMBL3713617

SCHEMBL3713617

O=[C]CCCNCc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.64
CHRM2 P08172 1/20 0.62
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
SIGMAR1 Q99720 3/20 0.58
GAA P10253 1/20 0.52
MAPT P10636 1/20 0.52
HDAC3 O15379 2/20 0.51
HDAC1 Q13547 2/20 0.51
HDAC2 Q92769 2/20 0.51
HDAC8 Q9BY41 2/20 0.51
NCOR2 Q9Y618 2/20 0.51
MPO P05164 1/20 0.49
ACHE P22303 4/20 0.47
ALDH1A1 P00352 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7057730 0.94 MAOA (0.68) MAOACHRM2MEN1KMT2ATDP1
SCHEMBL8812199 0.93 MAOA (0.71) MAOACHRM2MEN1KMT2ATDP1
SCHEMBL10695875 0.88 MEN1 (0.64) MAOACHRM2MEN1KMT2ATDP1
SCHEMBL10768243 0.83 SIGMAR1 (0.66) SIGMAR1GAAMAPT
SCHEMBL4932707 0.81 MAOA (0.95) MAOACHRM2MEN1KMT2ATDP1
SCHEMBL893154 0.81 MAOA (0.86) MAOACHRM2MEN1KMT2ATDP1
SCHEMBL7621212 0.81 MAOA (0.64) MAOACHRM2MEN1KMT2ATDP1
Hydrochloric Acid SCHEMBL9373176 0.79 MAOA (0.62) MAOACHRM2MEN1KMT2ATDP1
SCHEMBL4642587 0.79 MAOA (1.00) MAOACHRM2MEN1KMT2ATDP1
SCHEMBL16260102 0.79 MAOA (1.00) MAOACHRM2MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010106441-A2 PEPTIDOMIMETICS FOR MODULATING INTERLEUKIN-1 RECEPTOR CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE (CA) 2010-09-23 WO disclosed
EP-0252482-A2 7-Acyloxy-6-aminoacyloxypolyoxylabdanes, process for their preparation and their use as medicine HOECHST AKTIENGESELLSCHAFT (DE) 1988-01-13 EP disclosed